Connect with us

Cannabis News

The Psychonauts’ Guide to Bad Trips

Published

on


guide to a bad trip on acid

Psychonaut Guide to Bad Trips & Advice to the Permatripper

 

The realm of psychedelics is a fascinating and profound rabbit hole that has captivated countless individuals throughout human history. These mind-altering substances have the incredible ability to shatter our conventional ways of perceiving reality, propelling us into uncharted territories of consciousness exploration.

 

For many psychonauts, psychedelic journeys can be deeply transformative experiences, offering profound insights, emotional healing, and even spiritual awakenings. The veil of everyday perception is lifted, unveiling the sublime beauty and interconnectedness of all things. These transcendent states can instill a renewed sense of wonder, gratitude, and appreciation for the preciousness of life itself.

 

However, it’s crucial to approach this domain with the utmost respect and caution. Psychedelics are powerful tools that should not be trifled with. While they can catalyze immense personal growth, they also carry the potential for harm, especially when misused or taken in unsafe settings.

 

The cautionary tale that inspired this article comes from a fellow traveler who shared their unsettling experience on Reddit after accidentally ingesting what was likely an NBOMe compound, a dangerous synthetic psychedelic. Their harrowing journey was marred by physical discomfort, terrifying visuals, and lasting perceptual disturbances, serving as a sobering reminder of the risks associated with these powerful substances.

 

It is stories like these that underscore the importance of harm reduction, education, and responsible use within the psychedelic community. We must approach these sacred medicines with reverence, preparation, and a commitment to safety, lest we fall victim to their darker potentials.

 

In this article, we aim to impart wisdom and guidance to fellow psychonauts, drawing from both personal experiences and the collective knowledge of the psychedelic community. Our goal is to empower individuals with the tools and understanding necessary to navigate these realms safely and responsibly, minimizing potential harm while maximizing the profound benefits these substances can offer.

 

 

It’s crucial to understand that we’re dealing with a vast array of compounds, both natural and synthetic. The psychonaut who shared their harrowing experience serves as a stark reminder of the potential dangers lurking within this realm.

 

The legendary chemist Sasha Shulgin, often referred to as the “Godfather of Psychedelics,” dedicated his life to exploring the fascinating world of psychoactive compounds. Through his groundbreaking work detailed in books like “PiHKAL” and “TiHKAL,” Shulgin synthesized and bioassayed thousands of different substances, many of which exhibited psychedelic properties.

 

While Shulgin’s contributions have expanded our understanding of these compounds, they also highlight a sobering reality: there are potentially thousands of synthetic psychedelics out there, many of which are legal and can be produced in clandestine laboratories. These substances may resemble classic psychedelics like LSD or psilocybin in their chemical structure, but their effects and potential consequences remain largely unknown.

 

The classic psychedelics, such as LSD, psilocybin, and DMT, have undergone extensive human testing and research, albeit often in less-than-ideal conditions due to their legal status. However, with these synthetics, we lack crucial data on their safety, dosage, and potential long-term effects. Ingesting these compounds without proper knowledge and precautions can lead to disastrous consequences, as our Reddit friend painfully discovered.

 

The age-old adage, “If it’s bitter, it’s a spitter,” is a good rule of thumb when it comes to identifying potential impostors, as LSD is generally tasteless. However, relying solely on taste can be a risky gamble, and we should strive for more reliable methods of substance identification.

 

One relatively simple and inexpensive way to test for the presence of LSD is to use Ehrlich’s reagent, a chemical solution that changes color in the presence of certain indole compounds, including LSD. By applying a small amount of the reagent to a sample of the suspected substance, a purple color will indicate the presence of LSD, providing a much higher degree of certainty than relying on taste alone.

 

Moreover, it’s crucial to establish a trusted and reliable source for obtaining your desired psychedelic compounds. Building relationships with reputable individuals within the psychedelic community and cross-checking their credibility can go a long way in ensuring you’re getting what you expect. Additionally, exercising caution and performing thorough research before ingesting any new substance is an absolute must.

 

Drug prohibition has undoubtedly made it more difficult to access accurate information and reliable testing methods, but it’s our collective responsibility as psychonauts to prioritize harm reduction and safety. By empowering ourselves with knowledge, fostering community support, and advocating for sensible drug policies, we can navigate the psychedelic realms with greater confidence and mitigate the risks associated with these powerful substances.

 

 

Even with the utmost preparation and precautions, psychedelic journeys can sometimes veer off course, leading to unsettling or overwhelming experiences. In such moments, it’s crucial to remain grounded and avoid succumbing to panic, no matter how tempting it may be when faced with hallucinatory demons mocking your every move.

 

The first step in regaining control is to stop, take a deep breath, and focus on the simple act of breathing. As your mind races at a thousand miles per minute, consciously following the flow of air entering and exiting your body can serve as an anchor, grounding you in the present moment. Relax your body, accept the situation you find yourself in, and let go of any resistance.

 

One of the biggest catalysts for exacerbating the intensity of a challenging trip is fear and panic. The more you fight against the experience, the more it will fight back. Instead, embracing a mindset of acceptance and surrender can be the key to weathering the storm. Accept that you’re in an altered state, acknowledge that you’re not feeling your best, and simply be present with whatever arises, without judgment or resistance.

 

It’s often helpful to find a quiet, comfortable space where you can ride out the experience without external distractions or stimuli. Enlist the support of a trusted friend or trip-sitter who can periodically check in on you while giving you the space you need to navigate the inner realms.

 

Remind yourself of the mantra, “What goes up must come down.” While the intensity of a psychedelic experience can feel eternal in the moment, it’s important to remember that it is a temporary state. The effects will eventually subside, typically within 12 to 16 hours, depending on the dose and substance consumed. In some cases, the journey may extend even longer, but with patience and acceptance, the turbulence will eventually give way to calmer waters.

 

I once found myself in an extraordinarily prolonged state after consuming a substantial amount of peyote, tripping for an entire month. While challenging, this experience taught me the importance of surrendering to the experience, acknowledging that my body and nervous system were in a heightened state of alert. By embracing a mindset of acceptance and focusing on self-care practices like deep breathing and relaxation, I was able to shift back into a parasympathetic mode and eventually return to baseline.

 

Relaxing amidst the chaos of a psychedelic experience is no easy feat, but it can be the key to transforming a nightmare into a more manageable, even insightful, journey. By letting go of resistance, grounding yourself in the present moment, and trusting in the temporary nature of the experience, you can navigate even the roughest of trips with greater ease and grace.

 

 

While the novelty and excitement of a psychedelic experience can be alluring, it’s crucial to recognize that the true value of these substances extends far beyond mere recreational “tripping.” A psychedelic journey has the potential to catalyze profound internal transformation, facilitate the processing of past traumas, and offer a profound sense of connection to the universe and the very fabric of consciousness itself.

 

However, millions of individuals approach these substances with the sole intention of “tripping out,” treating them as little more than a means to an entertaining high. This mindset inherently disrespects the sacred nature of the psychedelic experience and increases the risk of encountering its darker aspects.

 

Throughout history, shamans and visionaries have been the true stewards of psychedelic wisdom, navigating the turbulent waters of these realms with reverence and purpose. They understood that these experiences were not mere “trips” but profound journeys, undertaken with the utmost respect and intention.

 

One of the quickest paths to encountering the more challenging aspects of psychedelics is to approach them casually, dismissing their power and treating them as a source of mere pleasure or entertainment. This disregard for their transformative potential can lead to harrowing experiences, as I discovered firsthand during a month-long peyote journey. Afterward, a shaman imparted the wisdom that the “Spirit of Peyote” had prolonged my trip as a lesson in respecting these sacred medicines.

 

Since then, I have adopted a stance of humility and reverence, patiently waiting for the invitation of the plant allies before embarking on a psychedelic experience. I cross-check that all factors align – set, setting, timing, and intention – before proceeding. When the conditions are right, I approach the experience with the understanding that I am undertaking a transformational journey, one that demands my utmost respect and dedication.

 

The true power of psychedelics lies not in the fleeting thrill of the “trip” itself but in the ability to integrate the lessons and insights gained into our waking lives. By approaching these experiences with humility and intention, we can uncover profound treasures within the realms of psychedelia and bring them back to this plane of existence in a functional and applicable manner.

 

Chasing the trip for its own sake is akin to playing Russian roulette with a bad experience. Sooner or later, the ego will be humbled, and a profoundly challenging journey may ensue. However, even in the face of such adversity, if we maintain an open and humble mindset, these experiences can catalyze significant positive change and personal growth.

 

Psychedelics are not mere recreational toys but powerful tools for self-exploration and transformation. By honoring their sacred nature, approaching them with reverence and intention, and committing to the integration of their lessons, we can unlock their full potential for personal growth and spiritual awakening.

 

 

The harrowing experience shared by our fellow psychonaut serves as a sobering reminder of the importance of responsibility, respect, and caution when venturing into the realms of psychedelia. Through the three lessons outlined in this article – knowing your substances, remaining grounded during challenging experiences, and approaching these journeys with reverence and intention – we aim to empower others to navigate these powerful territories safely and purposefully.

 

To the courageous individual who inspired this piece, we wish you a speedy recovery and integration of the lessons learned from your ordeal. Your willingness to share your story, no matter how difficult, has the potential to prevent others from falling into similar situations and to inspire a deeper appreciation for the sanctity of psychedelic experiences.

 

While your journey was undoubtedly challenging, may it ultimately serve as a catalyst for personal growth, wisdom, and a renewed commitment to treading these paths with the utmost care and respect. Your experience has not been in vain, for it has sparked a ripple of awareness that may guide countless others towards more mindful and transformative explorations of consciousness.

 

BAD TRIP ON PSCYCHEDELICS, READ ON…

HAVING A BAD TRIP DNA

HAVING A BAD TRIP MAY BE BECAUSE OF YOUR DNA SCIENCE SAYS!



Source link

Continue Reading

Cannabis News

California Appeals Court Rejects Marijuana Grow Permit, Citing Federal Illegality

Published

on

By


In a landmark decision that highlights the tension between state and federal cannabis laws, a California appellate court ruled on October 29th that property owners can refuse to allow the transportation of cannabis across their land via easements, even when the cannabis operation is approved by local authorities.

The Second District Court of Appeal’s unanimous decision draws attention to private property rights in a context where cannabis remains federally illegal, but state law allows licensed cultivation, distribution and sale. Presiding Justice Albert Gilbert stated, “No matter how much California voters and the Legislature might try, cannabis cultivation and transportation are illegal in California as long as it remains illegal under federal law.” JCCrandall LLC v. County of Santa Barbara, Case No. B333201, 2024 WL 4599304, Oct. 29, 2024.

Unless the California Supreme Court grants review – which I would not rule out – the decision empowers private property owners to refuse to contract with cannabis businesses, and restricts local government from approving cannabis operations that implicate the property rights of neighbors who object.

The case at hand

The dispute centered around a cannabis cultivation operation in Santa Barbara County, where JCCrandall LLC challenged a conditional use permit granted by the County to its neighbor, Santa Rita Holdings Inc. The critical issue was that Santa Rita Holdings could only access its 2.5-acre cannabis farm via an unpaved road crossing JCCrandall’s property through a pre-existing easement. JCCrandall grows oats and barley.

JCCrandall’s primary concern? It raised a number of complaints with the Santa Barbara County Supervisors about truck traffic and night operations, which did not gain traction, but in the Court of Appeal JCCrandall focused on what it claimed was potential liability associated with having federally illegal substances transported across its property, even though County regulators found that the Santa Rita operation was fully compliant with state and local laws.

Key legal findings

The appellate court’s decision hinged on several crucial points:

  1. Property Rights: The court emphasized that “the right to exclude others is the essence of the right of property ownership” and classified it as a fundamental vested right.
  2. Federal Supremacy: The panel determined that allowing cannabis transportation across private property “defies the Supremacy Clause” of the U.S. Constitution.
  3. State vs. Federal Law: While cannabis might be legal under California law, the court ruled that federal law’s prohibition takes precedence in this context.

California cannabis industry implications

Legal experts suggest this ruling could have far-reaching consequences for California’s cannabis industry. Section 1550.5(b) of the California Civil Code makes contracts within California involving cannabis lawful and enforceable, and Santa Rita Holdings bet the ranch on that argument. But the Court of Appeal held that the statute could not compel a landowner to allow cannabis to travel across its property on a pre-existing easement. Licensed operators may find it harder to do business because neighbors who have property rights affected by a cannabis business can object, and, under the JCCrandall ruling, local government must yield to those objections.

An example might be a cannabis dispensary that depends on access to its parking lot via an easement or is located in a shopping center where other lessees have rights to object to tenants notwithstanding the approval of the landlord. In cultivation, many cannabis farms depend on vehicular access through easements because they are remote and do not always have direct access to public thoroughfares, or they depend on water sourced from other properties pursuant to agreements made by prior owners who grew traditional crops. These neighbors might not need to show any negative impact on their property, but can argue that they could be found complicit in federally illegal activities.

I think the most problematic language in the JCCrandall ruling is the following, which might draw the attention of the California Supreme Court and cause it to grant review: “For as long as an easement is enjoyed, its mode and manner of use shall remain substantially the same as it was at the time the easement was created. The County argues the easement was used for agricultural purposes. But there is a vast difference between legal and illegal agricultural purposes.” (Emphasis added.) If California has determined that cannabis cultivation is legal – as it has – and state courts routinely enforce contracts involving cannabis, it is a pretty bold step to declare the use of a lawful pre-existing easement illegal simply because the agricultural crop is cannabis and take away easement access from Santa Rita.

Looking ahead

This decision creates new challenges for cannabis businesses in California, and will result in more disputes among neighbors. While the Biden administration has shown signs of easing federal marijuana restrictions, this ruling demonstrates that the federal-state law conflict continues to create significant legal hurdles for the cannabis industry.

California court decisions also can be persuasive authority in other states, so we might see similar litigation (and decisions) elsewhere in the country where cannabis has been legalized.

The case serves as a reminder that despite California’s progressive stance on cannabis, federal prohibition continues to cast a long shadow over the industry’s operations and development. As the cannabis landscape continues to evolve, this ruling may prompt businesses to reassess their property arrangements and local governments will certainly have to reconsider their permitting processes to give more careful consideration to objections by neighbors who claim that their property rights are implicated by cannabis operations.

Note: This post was first published earlier this month on the Alger ADR Blog.



Source link

Continue Reading

Cannabis News

Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?

Published

on

By


cannabis autoimmune problems

Why Are Autoimmune Conditions On The Rise? And How Cannabis Can Help

 

Autoimmune diseases refer to a group of medical conditions that occur as a result of the immune system attacking your own tissues.

 

In a normal human body, the immune system is responsible for protecting the body by producing antibodies that prevent toxins, cancer cells, and viruses from harming the body. However, when one is struck by an autoimmune disorder, the immune system is no longer able to distinguish the difference between dangerous cells and healthy cells. As a result, the healthy cells are attacked, too.

Today, we know of around 100 different kinds of autoimmune conditions. Some of the most common examples of autoimmune conditions include rheumatoid arthritis (RA), lupus, inflammatory bowel disease, celiac disease, Type 1 diabetes, multiple sclerosis (MS), and the Guillain-Barre syndrome (GBS) to name a few. Others include Graves’ disease, Hashimoto’s thyroiditis, psoriasis, and vasculitis.

 

According to the National Health Council, around 50 million Americans are affected by autoimmune diseases today. This is a conservative estimate, considering that several autoimmune conditions are tricky to treat and so many people go undiagnosed for long periods of time. It’s worrisome to note that there are more people developing autoimmune diseases these days, many of which have reached levels comparable to epidemics.

 

But cannabis can help!

 

How Cannabis Can Help Curb And Manage Autoimmune Diseases

 

Not one single cause is responsible for the alarming growth of autoimmune diseases, though there are several factors at play. While there isn’t just one cause we can point at, it’s certain the reasons lie in our environment. After all, human genetics haven’t changed significantly yet the chemicals, toxins, and pollutants in our food and everyday items have risen dramatically.

 

In addition, people are getting less sleep than ever; stress rates are through the roof, and people are constantly worried. There is a clear link between psychological stress and physical health as well as immunity, which is why it isn’t unusual – it’s even common – to see many autoimmune disease cases flare up after people experience severe stress caused by grief, an accident, job loss, or the death of a loved one. These highly stressful and traumatic conditions wreak havoc on the body’s immune response, causing inflammation all over the body.

 

Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include steroids but also some non-steroidal drugs. These drugs often come with unwanted side effects, but research has shown that cannabis can work with the endocannabinoid system through THC and CBD, as well as other cannabinoids, to simulate similar results. In one study for example, we can see the clear association of the endocannabinoid system for neurodegenerative and inflammatory processes seen in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.


There has also been an increasing number of studies proving the efficacy of cannabis for treating several autoimmune conditions.

 

Cannabis For Multiple Sclerosis

 

Multiple sclerosis is one of the autoimmune conditions where a growing number of studies have come out supporting the therapeutic benefits of cannabis for. In a 2024 study, patients with multiple sclerosis reported several improvements in quality of life after using cannabis-based medical products (CBMPs). For the study, British investigators analyzed the impact of cannabis based medicinal products made from either oil or extracts in 141 patients who were enrolled in the UK Medical Cannabis Registry.

 

The researchers then analyzed the changes in patient outcomes after a month, then three and 6 months after. According to the patients themselves, they were able to sustain improvements in their mental and physical health after marijuana therapy.

 

“This case series demonstrates a potential association between the initiation of CBMPs and improved patient reported outcomes in sleep, anxiety, and general HRQoL [health-related quality of life] measures, over six months,” said the study authors. “Additional measures for HRQoL, including various physical and mental health subdomains, also exhibit improvements up to six months when compared to baseline,” the authors concluded.

 

In another study from 2023, patients with multiple sclerosis reported significant improvements in symptoms after cannabis use. For the study, researchers from the Dent Neurologic Institute in Buffalo, New York, analyzed the medical records of 141 patients with multiple sclerosis, who were also legally authorized to consume medical marijuana products. They then analyzed data from the patients after one up to 4 follow-up sessions after the initial session of cannabis therapy. Sixty-five percent of patients consumed 1:1 THC:CBD tinctures.

 

According to the authors: “The results of this study indicate that use of MC [medical cannabis] to alleviate symptoms of MS is largely efficacious, with improvement in pain (72 percent of patients), muscle spasticity (48 percent of patients), and sleep disturbance (40 percent of patients) frequently reported.”

 

“More than half of opioid users at baseline were able to either discontinue or decrease their opioid use after starting MC. The mean daily MME [morphine milligram equivalents] was significantly reduced from the initial visit (51 mg) to the last follow-up visit (40 mg). This is consistent with previous literature showing that MC legalization is associated with decreased opioid use and that MC use is associated with decreased opioid use in patients with chronic pain. These findings indicate that MC may represent an alternative analgesic to opioids for some patients,” they wrote. 

 

Anecdotal Evidence

 

While more studies are needed to determine cannabis’ effect on other autoimmune conditions such as rheumatoid arthritis, we can rely on anecdotal evidence. In 2020, data from the medical journal, Rheumatology, revealed that patients who have this condition, along with those who have lupus and fibromyalgia, consume cannabis.

 

In fact, it was reported that marijuana was extremely common especially for patients with fibromyalgia. “In this meta-analysis, we found that one in six patients suffering from rheumatologic disease actively consumes cannabis, reducing pain reduction… A favorable effect of cannabis on pain in our meta-analysis reinforces the idea that cannabis could be used for analgesic purposes,” the authors concluded.

 

Conclusion

Cannabis is a safe and natural way to help prevent and treat the symptoms of autoimmune disease. It targets inflammation at its root, and is a proven natural way to help cope with stress, pain, insomnia, and inflammation all while protecting the brain. However, it’s important to ensure you medicate with clean, organic sources of marijuana.

 

AUTOIMMUNE AND CANNABIS, READ ON…

AUTOIMMUNE DISEASES THAT CANNABIS CAN HELP

CANNABIS FOR 9 DIFFERENT AUTOIMMUNE DISEASES!



Source link

Continue Reading

Cannabis News

Hemp and the New Senate Farm Bill

Published

on

By


The U.S. Senate’s version of the Farm Bill finally landed this week. They’re calling it the Rural Prosperity and Food Security Act of 2024 (the “Senate bill”). The Senate bill follows on the House’s proposal, called the Farm, Food and National Security Act of 2024 (the “House bill”), offered in May. Neither the Senate bill nor the House bill would preempt state or Indian law regarding hemp or the regulation of hemp products. This means states and tribes will retain a lot of latitude in regulating hemp and hemp-derived products– which gets people fired up.

Aside from giving states some runway, the Senate bill and the House bill differ in key respects regarding hemp. Therefore, these august bodies must confer and reconcile their sundry proposals. That could happen in 2024, but seems more likely in 2025 when the new Congress convenes. As of this week, though, we finally have a framework.

The Senate Bill re-defines “hemp” and defines “industrial hemp”

Section 10016 of the Senate bill (“Hemp Production”) amends the definition of “hemp.” Hemp was defined in the 2018 Farm Bill and removed from the federal Controlled Substances Act (CSA), taking us on a truly wild ride. See: What Happened to Hemp? (“What Happened”). The Senate bill also gives us a definition for “industrial hemp.” Here are those definitions, with points of emphasis in bold:

(1) Hemp. The term “hemp” means (A) the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis; and (B) industrial hemp.

(3) Industrial Hemp. The term “industrial hemp” means the plant Cannabis sativa L. if the harvested material (A) is only (i) the stalks of that plant, fiber produced from those stalks, or any other manufactured product, derivative, mixture, or preparation of those stalks (except cannabinoid resin extracted from those stalks); (ii) whole grain, oil, cake, nut, hull, or any other compound, manufactured product, derivative, mixture, or preparation of the seeds of that plant (except cannabinoid resin extracted from the seeds of that plant); or (iii) viable seeds of that plant produced solely for production or manufacture of any material described in clause (i) or (ii); and (B) will not be used in the manufacturing or synthesis of natural or synthetic cannabinoid products.

The new regime

Again, the definitional stuff in bold is what I want to emphasize.

First, the Senate bill keeps the THC threshold at 0.3 percent, which is an arbitrary number we’ve been advocating against for years. The Senate bill mirrors the House bill in this respect, though, so we are stuck with this, unless Ron Paul gets his way.

Second, the Senate bill keeps the 2018 Farm Bill’s total THC standard, including THCA. The House bill does this too. This was fairly predictable: in What Happened, I wrote that we could “expect the total THC standard to remain, which means that actual Delta-9 THC won’t be the only metric for calculating THC content.”

We’ve also explained on this blog that the 2018 Farm Bill and USDA rules mandate total THC testing on pre-harvest hemp batches, but do not mandate such testing on post-harvest hemp or hemp products. The Senate bill doesn’t change this paradigm, which means the “loophole” for gas station weed remains open. This proposal is a big win for opponents of the House bill’s “Miller Amendment,” which would narrow the definition of “hemp” to exclude intoxicating hemp-derived substances.

Third, the Senate bill introduces a new definition and framework for industrial hemp. The House bill does this too, albeit slightly differently. The idea here is to invite farmers to grow hemp for fiber and grain purposes, while freeing them from regulatory burdens with the Department of Agriculture and criminal exposure with the Department of Justice. More specifically, for “industrial hemp” growers, the Senate bill:

  • removes background check requirements;
  • instates “relaxed regulatory requirements” for sampling and inspection methodologies (which will need to be adopted by rule); and
  • develops a certified seed program. 

The Senate bill also makes any hemp producer ineligible to grow hemp for five years if that producer, “with a culpable mental state greater than negligence, produces a crop of hemp that is inconsistent with that license.”(Hint: use the seed program.) The proof standard here seems like it could be an issue, and even if anyone has been adjudicated as growing marijuana under the guise of hemp, Farm Bill ineligibility seems like a far-off concern.

Bottom line

The big takeaway for me is that the Senate bill leaves the door open for intoxicating hemp products, whereas the Miller Amendment to the House bill does not. Something’s gotta give. And it needs to happen soon, because we’re already long overdue. As I explained in a webinar last week, the Farm Bill deals with the nation’s entire food supply, not just hemp. Therefore, this is not like with the SAFE Banking Act, where we have a proposed law specific to cannabis that may or may not ever pass. The Farm Bill must pass, and soon.

Stay tuned and we’ll keep you updated on any major happenings. For more on this topic, check out our massive hemp and CBD archive, or these specific, recent posts:



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media